The current study investigated the expression of cathepsin B, L, and S in breast cancer TMAs to determine which patient and tumor characteristics are associated with expression of these proteases and which patients might therefore benefit from intraoperative, cathepsin-targeted NIR FI. Here, CTSB is linked to breast carcinoma.